Rapid intrapartum test for maternal group B streptococcal colonisation and its effect on antibiotic use in labouring women with risk factors for early-onset neonatal infection (GBS2): cluster randomised trial with nested test accuracy study
Jane P Daniels,Emily Dixon,Alicia Gill,Jon Bishop,Mark Wilks,Michael Millar,Jim Gray,Tracy E Roberts,Jane Plumb,Jonathan J Deeks,Karla Hemming,Khalid S Khan,Shakila Thangaratinam,GBS2 Collaborative Group,Khaled Ahmed,Julie Dodds,Maria D'Amico,Kostas Tryposkiadis,Angela Whiley,Patrick Moore,Ruvimbo Lorraine Munetsi,Pallavi Karkhanis,Anne Deans,Sanjula Sharma,Gemma Wright,Manjula Subramanian,Irene Ray,Dibyenda Datta,Lauren Lacey,Johnathon Pepper,Ruth Mason,Neil Shah,Katharina Anwar,Neena Navaneetham,Shad Husain,Phillip Bennett,Geraldine Masson,Hristina Raykova,Matthew Hogg,Bashir Dawalatly,Lakshmi Thirumalaikumar,Kate Townsend,Gerry Collins,Paul Heath,Kerry Hood,Stavros Petrou,Ben Stenson,Sarah McMullen,Julia Saunders,Alison Stanley,Stephen Walters,Patrick Bossuyt,Ruth Gilbert,Rhona Hughes
DOI: https://doi.org/10.1186/s12916-021-02202-2
2022-01-14
Abstract:Background: Mother-to-baby transmission of group B Streptococcus (GBS) is the main cause of early-onset infection. We evaluated whether, in women with clinical risk factors for early neonatal infection, the use of point-of-care rapid intrapartum test to detect maternal GBS colonisation reduces maternal antibiotic exposure compared with usual care, where antibiotics are administered due to those risk factors. We assessed the accuracy of the rapid test in diagnosing maternal GBS colonisation, against the reference standard of selective enrichment culture. Methods: We undertook a parallel-group cluster randomised trial, with nested test accuracy study and microbiological sub-study. UK maternity units were randomised to a strategy of rapid test (GeneXpert GBS system, Cepheid) or usual care. Within units assigned to rapid testing, vaginal-rectal swabs were taken from women with risk factors for vertical GBS transmission in established term labour. The trial primary outcome was the proportion of women receiving intrapartum antibiotics to prevent neonatal early-onset GBS infection. The accuracy of the rapid test was compared against the standard of selective enrichment culture in diagnosing maternal GBS colonisation. Antibiotic resistance profiles were determined in paired maternal and infant samples. Results: Twenty-two maternity units were randomised and 20 were recruited. A total of 722 mothers (749 babies) participated in rapid test units; 906 mothers (951 babies) were in usual care units. There was no evidence of a difference in the rates of intrapartum antibiotic prophylaxis (relative risk 1.16, 95% CI 0.83 to 1.64) between the rapid test (41%, 297/716) and usual care (36%, 328/906) units. No serious adverse events were reported. The sensitivity and specificity measures of the rapid test were 86% (95% CI 81 to 91%) and 89% (95% CI 85 to 92%), respectively. Babies born to mothers who carried antibiotic-resistant Escherichia coli were more likely to be colonised with antibiotic-resistant strains than those born to mothers with antibiotic-susceptible E. coli. Conclusion: The use of intrapartum rapid test to diagnose maternal GBS colonisation did not reduce the rates of antibiotics administered for preventing neonatal early-onset GBS infection than usual care, although with considerable uncertainty. The accuracy of the rapid test is within acceptable limits. Trial registration: ISRCTN74746075 . Prospectively registered on 16 April 2015.